Research published online on American Academy of Ophtalmology

Authors :

  • K. Hashemi, MD
  • I. Guber, MD
  • C. Bergin, PhD
  • F. Majo, MD, PhD

01/15

Reduced Precision of the Pentacam HR in Eyes with Mild to Moderate Keratoconus.

Abstract

Corneal-collagen crosslinking (CXL) is on the verge of achieving US Food and Drug Administration approval for treatment of progressive keratoconus (KCN)1,2; therefore, being able to accurately assess progression and the effect of CXL is a fundamental requirement for clinical management.3 Currently, the corneal tomography images from the Pentacam HR device (Oculus; Weltzar, Germany) are heavily relied on in the evaluation of KCN progression. Estimates of parameters such as corneal curvature and corneal thickness are analyzed serially over time to assess change.

+ Authors’ Information

1 Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.

2 Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland. Electronic address: francois.majo@fa2.ch.